Cardio Diagnostics Holdings Inc. - Common stock (CDIO)
1.8300
-0.2000 (-9.85%)
NASDAQ · Last Trade: Apr 9th, 3:23 PM EDT
Detailed Quote
| Previous Close | 2.030 |
|---|---|
| Open | 2.040 |
| Bid | 1.820 |
| Ask | 1.850 |
| Day's Range | 1.820 - 2.075 |
| 52 Week Range | 0.1500 - 7.910 |
| Volume | 142,015 |
| Market Cap | - |
| PE Ratio (TTM) | - |
| EPS (TTM) | - |
| Dividend & Yield | N/A (N/A) |
| 1 Month Average Volume | 298,969 |
Chart
About Cardio Diagnostics Holdings Inc. - Common stock (CDIO)
Cardio Diagnostics Holdings Inc. is a healthcare company focused on advancing personalized cardiovascular medicine through innovative diagnostic solutions. The company develops and commercializes cutting-edge technologies aimed at improving heart health management by offering comprehensive insights into individual cardiovascular risks. By leveraging advanced analytics and proprietary testing methodologies, Cardio Diagnostics seeks to empower healthcare providers and patients with actionable data to enhance decision-making and optimize treatment strategies for cardiovascular diseases. Their mission is to enhance patient outcomes and revolutionize the way cardiovascular health is understood and managed. Read More
News & Press Releases
BioMedNewsBreaks – Cardio Diagnostics Holdings, Inc. (NASDAQ: CDIO) Engages IBN to Support Corporate Communications Strategy
Cardio Diagnostics Holdings (NASDAQ: CDIO), a precision cardiovascular medicine company leveraging epigenetics, genetics and artificial intelligence, has engaged IBN to support its corporate communications strategy as it advances blood-based solutions for the prevention and detection of cardiovascular disease. The company develops and commercializes clinical tests and data platforms that integrate molecular biomarkers with AI to generate patient-specific insights, including Epi+Gen CHD(TM), a prescription-only test for assessing three-year coronary heart disease risk, PrecisionCHD(TM) for detection and management, HeartRisk(TM) for population-level intelligence and CardioInnovate360(TM) to support cardiovascular therapy development.
Via Investor Brand Network · April 8, 2026
Cardio Diagnostics Holdings Inc. (NASDAQ: CDIO) Is ‘One to Watch’
Cardio Diagnostics Holdings (NASDAQ: CDIO) is an artificial intelligence-powered precision cardiovascular medicine company focused on making cardiovascular disease prevention, detection, and management more accessible, personalized, and precise. The company’s approach is centered on advancing how cardiovascular disease is addressed by moving beyond traditional methods that rely on indirect or generalized indicators.
Via Investor Brand Network · March 31, 2026
Let's take a look at the stocks that are in motion in today's session.chartmill.com
Via Chartmill · March 13, 2026
Monday's session: top gainers and loserschartmill.com
Via Chartmill · March 2, 2026
Let's have a look at the top gainers and losers one hour before the close of the markets of today's session.chartmill.com
Via Chartmill · February 27, 2026
Which stocks have an unusual volume on Friday?chartmill.com
Via Chartmill · February 27, 2026
Gapping stocks in Friday's sessionchartmill.com
Via Chartmill · February 27, 2026
What's going on in today's pre-market sessionchartmill.com
Via Chartmill · February 27, 2026
Let's take a look at the stocks that are in motion in today's session.chartmill.com
Via Chartmill · February 25, 2026
The trading volume of these stocks is deviating from the norm in today's session.chartmill.com
Via Chartmill · February 25, 2026
Here are the top movers in Wednesday's session.chartmill.com
Via Chartmill · February 25, 2026
In today's session, these stocks are experiencing unusual volume.chartmill.com
Via Chartmill · February 24, 2026
As investors search for “top NASDAQ growth stocks 2026,” “small-cap breakout stocks,” and “functional beverage market growth,” several emerging names are gaining traction across financial platforms.
Via AB Newswire · February 20, 2026
Let's have a look at the top gainers and losers one hour before the close of the markets of today's session.chartmill.com
Via Chartmill · February 20, 2026
These stocks are the most active in today's sessionchartmill.com
Via Chartmill · February 20, 2026
Unusual volume stocks are being observed in Friday's session.chartmill.com
Via Chartmill · February 20, 2026
Let's uncover which stocks are experiencing notable gaps during today's session.chartmill.com
Via Chartmill · February 20, 2026
Which stocks are moving before the opening bell on Friday?chartmill.com
Via Chartmill · February 20, 2026
Which stocks have an unusual volume on Thursday?chartmill.com
Via Chartmill · February 19, 2026
BioMedNewsBreaks — Cardio Diagnostics Holdings, Inc. (NASDAQ: CDIO) Schedules Investor Conference Call for Feb. 19, 2026
Cardio Diagnostics Holdings (NASDAQ: CDIO) announced it will host an investor conference call on Feb. 19, 2026, at 3 p.m. Central Time to provide an overview of its precision molecular approach to cardiovascular disease prevention and early detection. The call will include updates on the company commercially available tests, Epi+Gen CHD(TM) and PrecisionCHD(TM), as well as discussion of recent clinical data, reimbursement progress and strategic growth initiatives.
Via Investor Brand Network · February 19, 2026
Get insights into the top gainers and losers of Wednesday's after-hours session.chartmill.com
Via Chartmill · February 18, 2026
Here are the top movers in Wednesday's session.chartmill.com
Via Chartmill · February 18, 2026
Top movers in Wednesday's sessionchartmill.com
Via Chartmill · February 18, 2026
Please replace the release dated February 17, 2026 with the following corrected version due to multiple revisions.
By Cardio Diagnostics Holdings, Inc. · Via Business Wire · February 18, 2026
Here are the top movers in Thursday's session.chartmill.com
Via Chartmill · January 8, 2026